WO2023027134A1 - 組成物 - Google Patents
組成物 Download PDFInfo
- Publication number
- WO2023027134A1 WO2023027134A1 PCT/JP2022/031963 JP2022031963W WO2023027134A1 WO 2023027134 A1 WO2023027134 A1 WO 2023027134A1 JP 2022031963 W JP2022031963 W JP 2022031963W WO 2023027134 A1 WO2023027134 A1 WO 2023027134A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- acid
- composition
- chemical formula
- radical
- present
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 82
- 239000003054 catalyst Substances 0.000 claims abstract description 31
- 239000002562 thickening agent Substances 0.000 claims abstract description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000000126 substance Substances 0.000 claims description 37
- 150000003839 salts Chemical class 0.000 claims description 16
- 239000002253 acid Substances 0.000 claims description 14
- 125000000217 alkyl group Chemical group 0.000 claims description 12
- 150000001450 anions Chemical class 0.000 claims description 11
- 150000003863 ammonium salts Chemical class 0.000 claims description 10
- 125000003118 aryl group Chemical group 0.000 claims description 8
- 239000002841 Lewis acid Substances 0.000 claims description 7
- 150000007517 lewis acids Chemical group 0.000 claims description 7
- 125000004432 carbon atom Chemical group C* 0.000 claims description 6
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 6
- 150000002500 ions Chemical class 0.000 claims description 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 4
- 230000007935 neutral effect Effects 0.000 claims description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 19
- -1 metals Chemical class 0.000 description 15
- UKLNMMHNWFDKNT-UHFFFAOYSA-M sodium chlorite Chemical compound [Na+].[O-]Cl=O UKLNMMHNWFDKNT-UHFFFAOYSA-M 0.000 description 14
- 229960002218 sodium chlorite Drugs 0.000 description 14
- 230000008859 change Effects 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 238000003860 storage Methods 0.000 description 9
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 7
- QBWCMBCROVPCKQ-UHFFFAOYSA-N chlorous acid Chemical compound OCl=O QBWCMBCROVPCKQ-UHFFFAOYSA-N 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- 229910052736 halogen Inorganic materials 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 229940077239 chlorous acid Drugs 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 4
- 229960001950 benzethonium chloride Drugs 0.000 description 4
- 229920002678 cellulose Polymers 0.000 description 4
- 239000001913 cellulose Substances 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 238000012790 confirmation Methods 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 238000004768 lowest unoccupied molecular orbital Methods 0.000 description 4
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 4
- 235000019345 sodium thiosulphate Nutrition 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 125000001424 substituent group Chemical group 0.000 description 4
- NHGXDBSUJJNIRV-UHFFFAOYSA-M tetrabutylammonium chloride Chemical compound [Cl-].CCCC[N+](CCCC)(CCCC)CCCC NHGXDBSUJJNIRV-UHFFFAOYSA-M 0.000 description 4
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 3
- 229920002581 Glucomannan Polymers 0.000 description 3
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- HSHXDCVZWHOWCS-UHFFFAOYSA-N N'-hexadecylthiophene-2-carbohydrazide Chemical compound CCCCCCCCCCCCCCCCNNC(=O)c1cccs1 HSHXDCVZWHOWCS-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 3
- 229960000686 benzalkonium chloride Drugs 0.000 description 3
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 3
- 239000003093 cationic surfactant Substances 0.000 description 3
- 229910001919 chlorite Inorganic materials 0.000 description 3
- 229910052619 chlorite group Inorganic materials 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229940046240 glucomannan Drugs 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 3
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 3
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 3
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 3
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 3
- 150000002576 ketones Chemical class 0.000 description 3
- 229920000609 methyl cellulose Polymers 0.000 description 3
- 239000001923 methylcellulose Substances 0.000 description 3
- 235000010981 methylcellulose Nutrition 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 3
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 125000001453 quaternary ammonium group Chemical group 0.000 description 3
- 230000009257 reactivity Effects 0.000 description 3
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- OKIZCWYLBDKLSU-UHFFFAOYSA-M N,N,N-Trimethylmethanaminium chloride Chemical compound [Cl-].C[N+](C)(C)C OKIZCWYLBDKLSU-UHFFFAOYSA-M 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 240000004584 Tamarindus indica Species 0.000 description 2
- 235000004298 Tamarindus indica Nutrition 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- HTZCNXWZYVXIMZ-UHFFFAOYSA-M benzyl(triethyl)azanium;chloride Chemical compound [Cl-].CC[N+](CC)(CC)CC1=CC=CC=C1 HTZCNXWZYVXIMZ-UHFFFAOYSA-M 0.000 description 2
- 210000000692 cap cell Anatomy 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 239000000645 desinfectant Substances 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- QFWPJPIVLCBXFJ-UHFFFAOYSA-N glymidine Chemical compound N1=CC(OCCOC)=CN=C1NS(=O)(=O)C1=CC=CC=C1 QFWPJPIVLCBXFJ-UHFFFAOYSA-N 0.000 description 2
- 229920000591 gum Polymers 0.000 description 2
- 125000001072 heteroaryl group Chemical group 0.000 description 2
- 229960002050 hydrofluoric acid Drugs 0.000 description 2
- GEOVEUCEIQCBKH-UHFFFAOYSA-N hypoiodous acid Chemical compound IO GEOVEUCEIQCBKH-UHFFFAOYSA-N 0.000 description 2
- 150000007529 inorganic bases Chemical class 0.000 description 2
- SRPSOCQMBCNWFR-UHFFFAOYSA-N iodous acid Chemical compound OI=O SRPSOCQMBCNWFR-UHFFFAOYSA-N 0.000 description 2
- 150000004715 keto acids Chemical class 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000000693 micelle Substances 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 229920005615 natural polymer Polymers 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 150000007530 organic bases Chemical class 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 2
- 229920000058 polyacrylate Polymers 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- HUJXHFRXWWGYQH-UHFFFAOYSA-O sinapine Chemical compound COC1=CC(\C=C\C(=O)OCC[N+](C)(C)C)=CC(OC)=C1O HUJXHFRXWWGYQH-UHFFFAOYSA-O 0.000 description 2
- 229910021647 smectite Inorganic materials 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- KILNVBDSWZSGLL-KXQOOQHDSA-N 1,2-dihexadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC KILNVBDSWZSGLL-KXQOOQHDSA-N 0.000 description 1
- TZSYLWAXZMNUJB-UHFFFAOYSA-N 1-methylpyridin-1-ium-3-carboxylic acid;chloride Chemical compound [Cl-].C[N+]1=CC=CC(C(O)=O)=C1 TZSYLWAXZMNUJB-UHFFFAOYSA-N 0.000 description 1
- 125000001637 1-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C(*)=C([H])C([H])=C([H])C2=C1[H] 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- QVFHQENRNSAHEK-UHFFFAOYSA-M 2-benzoyloxyethyl(trimethyl)azanium;chloride Chemical compound [Cl-].C[N+](C)(C)CCOC(=O)C1=CC=CC=C1 QVFHQENRNSAHEK-UHFFFAOYSA-M 0.000 description 1
- JOYAGGCGGYOYRW-UHFFFAOYSA-M 2-dodecanoyloxyethyl(trimethyl)azanium;chloride;hydrate Chemical compound O.[Cl-].CCCCCCCCCCCC(=O)OCC[N+](C)(C)C JOYAGGCGGYOYRW-UHFFFAOYSA-M 0.000 description 1
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 description 1
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- PXACTUVBBMDKRW-UHFFFAOYSA-N 4-bromobenzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=C(Br)C=C1 PXACTUVBBMDKRW-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- DHHFDKNIEVKVKS-FMOSSLLZSA-N Betanin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC(C[C@H]2C([O-])=O)=C1[N+]2=C\C=C\1C=C(C(O)=O)N[C@H](C(O)=O)C/1 DHHFDKNIEVKVKS-FMOSSLLZSA-N 0.000 description 1
- DHHFDKNIEVKVKS-MVUYWVKGSA-N Betanin Natural products O=C(O)[C@@H]1NC(C(=O)O)=C/C(=C\C=[N+]/2\[C@@H](C(=O)[O-])Cc3c\2cc(O)c(O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)c3)/C1 DHHFDKNIEVKVKS-MVUYWVKGSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- CXRFDZFCGOPDTD-UHFFFAOYSA-M Cetrimide Chemical compound [Br-].CCCCCCCCCCCCCC[N+](C)(C)C CXRFDZFCGOPDTD-UHFFFAOYSA-M 0.000 description 1
- 235000019743 Choline chloride Nutrition 0.000 description 1
- RUPBZQFQVRMKDG-UHFFFAOYSA-M Didecyldimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCC[N+](C)(C)CCCCCCCCCC RUPBZQFQVRMKDG-UHFFFAOYSA-M 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- VWLHWLSRQJQWRG-UHFFFAOYSA-O Edrophonum Chemical compound CC[N+](C)(C)C1=CC=CC(O)=C1 VWLHWLSRQJQWRG-UHFFFAOYSA-O 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-N Nitrous acid Chemical compound ON=O IOVCWXUNBOPUCH-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- RVOLLAQWKVFTGE-UHFFFAOYSA-N Pyridostigmine Chemical compound CN(C)C(=O)OC1=CC=C[N+](C)=C1 RVOLLAQWKVFTGE-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 description 1
- ANGKOCUUWGHLCE-HKUYNNGSSA-N [(3s)-1,1-dimethylpyrrolidin-1-ium-3-yl] (2r)-2-cyclopentyl-2-hydroxy-2-phenylacetate Chemical compound C1[N+](C)(C)CC[C@@H]1OC(=O)[C@](O)(C=1C=CC=CC=1)C1CCCC1 ANGKOCUUWGHLCE-HKUYNNGSSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 239000005456 alcohol based solvent Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 description 1
- 125000004414 alkyl thio group Chemical group 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 239000001654 beetroot red Substances 0.000 description 1
- 235000012677 beetroot red Nutrition 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 235000016614 betalains Nutrition 0.000 description 1
- 235000002185 betanin Nutrition 0.000 description 1
- NZUPCNDJBJXXRF-UHFFFAOYSA-O bethanechol Chemical compound C[N+](C)(C)CC(C)OC(N)=O NZUPCNDJBJXXRF-UHFFFAOYSA-O 0.000 description 1
- 229960000910 bethanechol Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- SXDBWCPKPHAZSM-UHFFFAOYSA-N bromic acid Chemical compound OBr(=O)=O SXDBWCPKPHAZSM-UHFFFAOYSA-N 0.000 description 1
- 229940006460 bromide ion Drugs 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- DKSMCEUSSQTGBK-UHFFFAOYSA-N bromous acid Chemical compound OBr=O DKSMCEUSSQTGBK-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- AIXAANGOTKPUOY-UHFFFAOYSA-N carbachol Chemical compound [Cl-].C[N+](C)(C)CCOC(N)=O AIXAANGOTKPUOY-UHFFFAOYSA-N 0.000 description 1
- 229960004484 carbachol Drugs 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- WOWHHFRSBJGXCM-UHFFFAOYSA-M cetyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)C WOWHHFRSBJGXCM-UHFFFAOYSA-M 0.000 description 1
- 239000013626 chemical specie Substances 0.000 description 1
- XTEGARKTQYYJKE-UHFFFAOYSA-N chloric acid Chemical compound OCl(=O)=O XTEGARKTQYYJKE-UHFFFAOYSA-N 0.000 description 1
- 229940005991 chloric acid Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- QWJSAWXRUVVRLH-UHFFFAOYSA-M choline bitartrate Chemical compound C[N+](C)(C)CCO.OC(=O)C(O)C(O)C([O-])=O QWJSAWXRUVVRLH-UHFFFAOYSA-M 0.000 description 1
- 229960004874 choline bitartrate Drugs 0.000 description 1
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 description 1
- 229960003178 choline chloride Drugs 0.000 description 1
- KRVSOGSZCMJSLX-UHFFFAOYSA-L chromic acid Substances O[Cr](O)(=O)=O KRVSOGSZCMJSLX-UHFFFAOYSA-L 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- CVKFXBUVLBFHGO-UHFFFAOYSA-N cobalt 5,10,15,20-tetraphenyl-21,23-dihydroporphyrin Chemical compound [Co].c1cc2nc1c(-c1ccccc1)c1ccc([nH]1)c(-c1ccccc1)c1ccc(n1)c(-c1ccccc1)c1ccc([nH]1)c2-c1ccccc1 CVKFXBUVLBFHGO-UHFFFAOYSA-N 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- VWTINHYPRWEBQY-UHFFFAOYSA-N denatonium Chemical compound [O-]C(=O)C1=CC=CC=C1.C=1C=CC=CC=1C[N+](CC)(CC)CC(=O)NC1=C(C)C=CC=C1C VWTINHYPRWEBQY-UHFFFAOYSA-N 0.000 description 1
- 229940006275 denatonium Drugs 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 229960004670 didecyldimethylammonium chloride Drugs 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229960003748 edrophonium Drugs 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000005357 flat glass Substances 0.000 description 1
- AWJWCTOOIBYHON-UHFFFAOYSA-N furo[3,4-b]pyrazine-5,7-dione Chemical compound C1=CN=C2C(=O)OC(=O)C2=N1 AWJWCTOOIBYHON-UHFFFAOYSA-N 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229960002462 glycopyrronium bromide Drugs 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 125000001183 hydrocarbyl group Chemical group 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 229940071870 hydroiodic acid Drugs 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- CUILPNURFADTPE-UHFFFAOYSA-N hypobromous acid Chemical compound BrO CUILPNURFADTPE-UHFFFAOYSA-N 0.000 description 1
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 description 1
- AQYSYJUIMQTRMV-UHFFFAOYSA-N hypofluorous acid Chemical compound FO AQYSYJUIMQTRMV-UHFFFAOYSA-N 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229920000592 inorganic polymer Polymers 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 description 1
- 229940006461 iodide ion Drugs 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- DEQXHPXOGUSHDX-UHFFFAOYSA-N methylaminomethanetriol;hydrochloride Chemical compound Cl.CNC(O)(O)O DEQXHPXOGUSHDX-UHFFFAOYSA-N 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 229960002362 neostigmine Drugs 0.000 description 1
- LULNWZDBKTWDGK-UHFFFAOYSA-M neostigmine bromide Chemical compound [Br-].CN(C)C(=O)OC1=CC=CC([N+](C)(C)C)=C1 LULNWZDBKTWDGK-UHFFFAOYSA-M 0.000 description 1
- 229910001120 nichrome Inorganic materials 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000008375 oral care agent Substances 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- RXCVUXLCNLVYIA-UHFFFAOYSA-N orthocarbonic acid Chemical compound OC(O)(O)O RXCVUXLCNLVYIA-UHFFFAOYSA-N 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- NVOYVOBDTVTBDX-PMEUIYRNSA-N oxitropium Chemical compound CC[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)C1=CC=CC=C1 NVOYVOBDTVTBDX-PMEUIYRNSA-N 0.000 description 1
- 229960000797 oxitropium Drugs 0.000 description 1
- 239000000123 paper Substances 0.000 description 1
- FIKAKWIAUPDISJ-UHFFFAOYSA-L paraquat dichloride Chemical compound [Cl-].[Cl-].C1=C[N+](C)=CC=C1C1=CC=[N+](C)C=C1 FIKAKWIAUPDISJ-UHFFFAOYSA-L 0.000 description 1
- LLYCMZGLHLKPPU-UHFFFAOYSA-N perbromic acid Chemical compound OBr(=O)(=O)=O LLYCMZGLHLKPPU-UHFFFAOYSA-N 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- YHHSONZFOIEMCP-UHFFFAOYSA-O phosphocholine Chemical compound C[N+](C)(C)CCOP(O)(O)=O YHHSONZFOIEMCP-UHFFFAOYSA-O 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 229960003975 potassium Drugs 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 229940086066 potassium hydrogencarbonate Drugs 0.000 description 1
- JBKPUQTUERUYQE-UHFFFAOYSA-O pralidoxime Chemical compound C[N+]1=CC=CC=C1\C=N\O JBKPUQTUERUYQE-UHFFFAOYSA-O 0.000 description 1
- 229960003370 pralidoxime Drugs 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 229960002290 pyridostigmine Drugs 0.000 description 1
- 238000003077 quantum chemistry computational method Methods 0.000 description 1
- OARRHUQTFTUEOS-UHFFFAOYSA-N safranin Chemical compound [Cl-].C=12C=C(N)C(C)=CC2=NC2=CC(C)=C(N)C=C2[N+]=1C1=CC=CC=C1 OARRHUQTFTUEOS-UHFFFAOYSA-N 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 229940120904 succinylcholine chloride Drugs 0.000 description 1
- YOEWQQVKRJEPAE-UHFFFAOYSA-L succinylcholine chloride (anhydrous) Chemical compound [Cl-].[Cl-].C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C YOEWQQVKRJEPAE-UHFFFAOYSA-L 0.000 description 1
- BUUPQKDIAURBJP-UHFFFAOYSA-N sulfinic acid Chemical compound OS=O BUUPQKDIAURBJP-UHFFFAOYSA-N 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- ISIJQEHRDSCQIU-UHFFFAOYSA-N tert-butyl 2,7-diazaspiro[4.5]decane-7-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCCC11CNCC1 ISIJQEHRDSCQIU-UHFFFAOYSA-N 0.000 description 1
- HWCKGOZZJDHMNC-UHFFFAOYSA-M tetraethylammonium bromide Chemical compound [Br-].CC[N+](CC)(CC)CC HWCKGOZZJDHMNC-UHFFFAOYSA-M 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- WWNNZCOKKKDOPX-UHFFFAOYSA-N trigonelline Natural products C[N+]1=CC=CC(C([O-])=O)=C1 WWNNZCOKKKDOPX-UHFFFAOYSA-N 0.000 description 1
- 239000013638 trimer Substances 0.000 description 1
- 229930195735 unsaturated hydrocarbon Natural products 0.000 description 1
- 235000008979 vitamin B4 Nutrition 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 238000004383 yellowing Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N33/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic nitrogen compounds
- A01N33/02—Amines; Quaternary ammonium compounds
- A01N33/04—Nitrogen directly attached to aliphatic or cycloaliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
- A01N59/08—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A01P1/00—Disinfectants; Antimicrobial compounds or mixtures thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A01P3/00—Fungicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/20—Halogens; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L9/00—Disinfection, sterilisation or deodorisation of air
- A61L9/01—Deodorant compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/02—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
Definitions
- the present invention relates to compositions, and more particularly to compositions that generate radicals.
- Radicals are important chemical species that are widely used due to their high reactivity and strong oxidizing power. For example, when bacteria and viruses come into contact with radicals, they are extinguished (also called inactivation) due to their oxidative power, so effects such as sterilization and deodorization can be obtained. It's being used.
- Patent Document 1 includes a radical generation catalyst and a radical generation source, and the radical generation catalyst is at least one of ammonium and its salt, and Lewis acidity and Bronsted acidity. Substances with at least one and drugs containing one or both have been proposed.
- Cited Document 1 The drug described in Cited Document 1 is mixed with water, an organic solvent, etc., and is used by spraying or applying to an object, and is used as a liquid preparation.
- formulation design has diversified in order to create a suitable dosage form according to the place of use, purpose of use, application, etc. It is demanded to use the product in a new dosage form.
- an object of the present invention is to provide a new form of a composition containing a radical generation source and a radical generation catalyst.
- the present invention is achieved by the following (1) to (7).
- a composition containing (a) a radical generating catalyst, (b) a radical generating source, (c) a thickening agent and (d) water.
- the radical generating catalyst is a Lewis acid having a Lewis acidity of 0.4 eV or more.
- the radical generating catalyst contains an ammonium salt represented by the following chemical formula (I).
- R 1 , R 2 , R 3 and R 4 are the same or different and each represents a hydrogen atom or an alkyl group, an ether bond, a carbonyl group, an ester bond or an amide bond, or an aromatic ring. and X ⁇ is an anion.
- the ammonium salt represented by the chemical formula (I) is an ammonium salt represented by the following chemical formula (II).
- R 11 is an alkyl group having 5 to 40 carbon atoms, which may contain an ether bond, a carbonyl group, an ester bond, an amide bond, or an aromatic ring, and R 2 and X 1 - is the same as in the chemical formula (I).
- R 11 and X - are the same as in the chemical formula (II).
- the radical-generating source is at least one selected from the group consisting of halogenous acid, halogenous acid ions and halogenous salts.
- the composition is neutral or alkaline.
- compositions of the present invention are easy to handle, for example, easy to spread over the application.
- FIG. 1 is a diagram showing the results of a temporal test of sodium chlorite content in the sample composition of Test Example 3, FIG. 1(a) is Example 11, FIG. 1(c) is Example 13, FIG. 1(d) is Example 14, and FIG. 1(e) is Example 15.
- FIG. FIG. 2 is a diagram showing the results of the viscosity test over time of the sample composition of Test Example 4, FIG. 2(a) is Example 11, FIG. 2(b) is Example 12, and FIG. is Example 13, FIG. 2(d) is Example 14, and FIG. 2(e) is Example 15.
- FIG. 1 is a diagram showing the results of a temporal test of sodium chlorite content in the sample composition of Test Example 3
- FIG. 1(a) is Example 11
- FIG. 1(d) is Example 13
- FIG. 1(e) is Example 15.
- FIG. 2 is a diagram showing the results of the viscosity test over time of the sample composition of Test Example 4
- FIG. 2(a) is Example 11
- FIG. 2(b)
- composition of the present invention contains (a) a radical generation catalyst, (b) a radical generation source, (c) a thickener and (d) water. Each component will be described below.
- the radical-generating catalyst contained in the composition of the present invention (hereinafter sometimes referred to as "the radical-generating catalyst of the present invention") is not particularly limited as long as it catalyzes radical generation from a radical-generating source. can be used.
- the radical generating catalyst may be used alone or in combination of two or more.
- a Lewis acid is preferably used as the radical generation catalyst, and a Lewis acid having a Lewis acidity of 0.4 eV or more is more preferable.
- the upper limit of the Lewis acidity is not particularly limited, it is preferably 20 eV or less.
- the Lewis acidity is described, for example, in Ohkubo, K.; Fukuzumi, S. Chem. Eur. J., 2000, 6, 4532, J. AM. CHEM. SOC. Org. Chem. 2003, 68, 4720-4726. Specifically, it can be measured by the following method.
- CoTPP Cobalt tetraphenylporphyrin
- saturated O2 and Lewis acidity measurands e.g. cations such as metals, represented by Mn + in Reaction Scheme (A) below
- MeCN Acetonitrile
- a ⁇ E value (eV) which is an index of Lewis acidity, can be calculated from the obtained reaction rate constant (kcat).
- kcat reaction rate constant
- a larger value of kcat indicates stronger Lewis acidity.
- the Lewis acidity of an organic compound can also be estimated from the lowest unoccupied molecular orbital (LUMO) energy level calculated by quantum chemical calculation. A larger value on the positive side indicates stronger Lewis acidity.
- LUMO unoccupied molecular orbital
- the radical generation catalyst of the present invention is preferably ammonium or a salt thereof having properties as a Lewis acid.
- ammonium may be, for example, quaternary ammonium, tertiary, secondary, primary or zero-class ammonium.
- ammonium and its salts examples include cationic surfactants, among which quaternary ammonium-type cationic surfactants are preferred.
- quaternary ammonium cationic surfactants include benzalkonium chloride, benzethonium chloride, cetylpyridinium chloride, hexadecyltrimethylammonium bromide, decalinium chloride, edrophonium, didecyldimethylammonium chloride, tetramethylammonium chloride, Tetrabutylammonium chloride, benzyltriethylammonium chloride, oxitropium, carbachol, glycopyrronium, safranin, sinapine, tetraethylammonium bromide, hexadecyltrimethylammonium bromide, suxamethonium, sphingomyelin, denatonium, trigonelline, neostigmine, paraquat, pyridostigmine , ferrodendrin, pralidoxime methyl iodide, betaine, betanin, bethane
- the quaternary ammonium is not limited to surfactants only.
- the ammonium may be, for example, ammonium represented by the following chemical formula (I).
- R 1 , R 2 , R 3 and R 4 are the same or different and each represents a hydrogen atom or an alkyl group, an ether bond, a ketone (carbonyl group), an ester bond or an amide bond, Or it may contain an aromatic ring and X 1 — is an anion.
- the alkyl group is preferably a linear or branched alkyl group having 1 to 40 carbon atoms.
- Ammonium represented by the chemical formula (I) is preferably ammonium represented by the following chemical formula (II).
- R 11 is an alkyl group having 5 to 40 carbon atoms, which may contain an ether bond, a ketone (carbonyl group), an ester bond, an amide bond, or an aromatic ring; R 2 and X - are the same as in the chemical formula (I).
- R 2 is preferably a methyl group or a benzyl group, and the benzyl group is unsubstituted even if one or more of the hydrogen atoms in the benzene ring are substituted with arbitrary substituents.
- the optional substituents are, for example, alkyl groups, unsaturated aliphatic hydrocarbon groups, aryl groups, heteroaryl groups, halogens, hydroxy groups (--OH), mercapto groups (--SH), alkylthio groups ( —SR, R is an alkyl group).
- Ammonium represented by the chemical formula (II) is preferably ammonium represented by the following chemical formula (III).
- ammonium represented by the chemical formula (I) examples include benzethonium chloride, benzalkonium chloride, hexadecyltrimethylammonium chloride, tetramethylammonium chloride, ammonium chloride, and tetrabutylammonium chloride. It is preferably at least one selected from the group consisting of Among them, the benzethonium chloride represented by the formula (II) is particularly preferred.
- Benzethonium chloride (Bzn + Cl ⁇ ) can be represented, for example, by the following chemical formula (IV).
- Me is a methyl group and t Bu is a tertiary butyl group.
- benzalkonium chloride can be expressed as a compound in which R 11 is an alkyl group having 8 to 18 carbon atoms and X 1 - is a chloride ion in the chemical formula (III).
- X 1 ⁇ is an arbitrary anion and is not particularly limited. Also, X 1 ⁇ is not limited to a monovalent anion, and may be an anion of any valence such as divalent or trivalent.
- the anion has a plurality of charges such as divalent and trivalent, for example, the number of molecules of ammonium (monovalent) in the chemical formulas (I), (II) and (III) is the number of anion molecules x the valence of the anion. number (for example, when the anion is divalent, the number of molecules of ammonium (monovalent) is twice the number of molecules of the anion).
- Examples of X ⁇ include halogen ions (fluoride ion, chloride ion, bromide ion, iodide ion), acetate ion, nitrate ion, sulfate ion and the like.
- the ammonium may contain a plurality of ammonium structures (N + ) in one molecule. Further, the ammonium may form a dimer, trimer, or the like by, for example, association of a plurality of molecules through ⁇ -electron interaction.
- a compound e.g., the organic ammonium, etc.
- isomers such as tautomers or stereoisomers (e.g., geometric isomers, conformational isomers, and optical isomers)
- Any isomer can be used in the present invention unless otherwise indicated.
- the salt when the compound (eg, the organic ammonium, etc.) can form a salt, the salt may be an acid addition salt or a base addition salt.
- the acid forming the acid addition salt may be an inorganic acid or an organic acid
- the base forming the base addition salt may be an inorganic base or an organic base.
- inorganic acid examples include, but are not limited to, sulfuric acid, phosphoric acid, hydrofluoric acid, hydrochloric acid, hydrobromic acid, hydroiodic acid, hypofluorous acid, hypochlorous acid, hypobromous acid, Hypoiodous acid, fluorous acid, chlorous acid, bromous acid, iodous acid, fluoric acid, chloric acid, bromic acid, iodic acid, perfluoric acid, perchloric acid, perbromic acid, periodic acid, etc. is mentioned.
- the organic acid is also not particularly limited, and examples thereof include p-toluenesulfonic acid, methanesulfonic acid, oxalic acid, p-bromobenzenesulfonic acid, carbonic acid, succinic acid, citric acid, benzoic acid and acetic acid.
- the inorganic base is not particularly limited, but includes, for example, ammonium hydroxide, alkali metal hydroxide, alkaline earth metal hydroxide, carbonate and hydrogen carbonate.
- the organic base is also not particularly limited, and examples thereof include ethanolamine, triethylamine and tris(hydroxymethyl)aminomethane.
- the method for producing these salts is not particularly limited, either, and they can be produced, for example, by adding an acid or base as described above to the above compounds as appropriate by a known method.
- chain substituents e.g., hydrocarbon groups such as alkyl groups and unsaturated aliphatic hydrocarbon groups
- chain substituents may be linear or branched unless otherwise specified, and the number of carbon atoms thereof is , but not particularly limited, in the following order of preference, 1 to 40, 1 to 32, 1 to 24, 1 to 18, 1 to 12, 1 to 6, or 1 to 2 (2 or more in the case of an unsaturated hydrocarbon group) is.
- the number of ring members (the number of atoms constituting the ring) of the cyclic group eg, aryl group, heteroaryl group, etc.
- any isomer may be used unless otherwise specified.
- naphthyl group it may be a 1-naphthyl group or a 2-naphthyl group.
- the content of the radical generation catalyst is preferably 0.01 to 1500 mass ppm. If the concentration of the radical-generating catalyst in the composition is too low, the generation of radicals will be suppressed, and there is a risk that the bactericidal effect and the like will not be obtained. Moreover, it is preferable that the content of the radical generation catalyst is 1500 ppm by mass or less because safety can be ensured.
- the content of the radical generation catalyst in the composition is more preferably 0.1 to 1000 mass ppm, still more preferably 0.1 to 500 mass ppm, particularly preferably 1 to 200 mass ppm, and 1 to 100 mass ppm. ppm is most preferred. From the viewpoint of preventing the bactericidal effect from being lost due to micelle formation, it is preferable that the concentration of the radical generating catalyst is equal to or lower than the micelle limit concentration.
- Radical generating sources include, for example, halogen ions, hypohalite ions, halous ions, halogen ions, perhalogen ions, etc., and preferably contain at least one selected from the group consisting of these.
- Radical generators may include, for example, oxoacids or salts thereof (eg, halogen oxoacids or salts thereof).
- oxoacid examples include boric acid, carbonic acid, orthocarbonic acid, carboxylic acid, silicic acid, nitrous acid, nitric acid, phosphorous acid, phosphoric acid, arsenic, sulfurous acid, sulfuric acid, sulfonic acid, sulfinic acid, chromic acid, and nichrome. acid, permanganic acid, and the like.
- Halogen oxoacids include chloroxoacids such as hypochlorous, chlorous, chloric and perchloric acids; bromine oxoacids such as hypobromous, bromous, bromic and perbromic; Iodine oxoacids such as hypoiodous acid, iodous acid, iodic acid, and periodic acid.
- these salts include alkali metal salts such as sodium and potassium.
- the radical generating source is at least one selected from the group consisting of halogenous acid, halogenous acid ion and halogenous acid salt, and has moderate reactivity with the radical generating catalyst to control the reaction.
- At least one selected from the group consisting of chlorous acid, chlorite ions, and chlorites is more preferable because it is easy to remove. Specifically, sodium chlorite is preferred.
- the content of the radical generating source is preferably 0.01 to 1500 mass ppm. If the concentration of the radical-generating source in the composition is too low, the amount of radicals generated is too small, and there is a risk that the bactericidal effect and the like cannot be obtained. Further, the higher the concentration of the radical generating source, the better the bactericidal effect and the like.
- the content of the radical generating source is more preferably 1 to 1000 mass ppm, still more preferably 10 to 500 mass ppm, and particularly preferably 50 to 250 mass ppm in the composition.
- the concentration ratio of the radical generation source and the radical generation catalyst (radical generation source/radical generation catalyst) in the composition is not particularly limited and can be set as appropriate.
- a water-soluble thickener can be suitably used as the thickener.
- nonionic thickeners and amphoteric thickeners are preferred.
- water-soluble thickeners include cellulose-based thickeners such as hydroxypropylcellulose, hydroxypropylmethylcellulose, and methylcellulose, polysaccharides such as glucomannan, tamarind gum, xanthan gum, guar gum, gum arabic, locust bean gum, and agar ( natural polymers); inorganic polymers such as smectite; acrylic polymers (synthetic polymers) such as sodium polyacrylate and crosslinked sodium polyacrylate; These may be used individually by 1 type, and may be used in combination of 2 or more type.
- Chlorous acid which is suitably used as a radical generation source, is a highly useful radical generation source, but it may decompose and decrease depending on the coexisting components.
- cellulose-based thickeners such as hydroxypropylcellulose, hydroxypropylmethylcellulose and methylcellulose, polysaccharides (natural polymers) such as glucomannan and tamarind gum, Acrylic polymers such as sodium polyacrylate and smectite are found to be less likely to cause the decomposition of chlorous acid, and are selected from the group consisting of chlorous acid, chlorite ions, and chlorite as radical generation sources.
- cellulose-based thickeners such as hydroxypropylcellulose, hydroxypropylmethylcellulose, and methylcellulose are particularly suitable because they are excellent in long-term thickening stability of the composition.
- the content of the thickening agent may be appropriately adjusted according to the type of thickening agent used and the desired viscosity of the composition. is preferred.
- the content of the thickener is 0.1% by mass or more, excessive decrease in the viscosity of the composition is suppressed, thereby improving handling properties, and when the content is 20% by mass or less, excessive increase in viscosity. is suppressed, so the usability can be improved.
- composition of the present invention contains water as a solvent for dissolving or dispersing the radical generating catalyst, radical generating source and thickener.
- Examples of water include purified water, ion-exchanged water, distilled water, filtered water, and sterilized water.
- composition of the present invention may contain, as additives, components other than the above-described radical generating catalyst, radical generating source, thickener and water as long as the effects of the present invention are not impaired.
- Other components include, for example, organic solvents and pH adjusters.
- organic solvent examples include ketones such as acetone, nitrile solvents such as acetonitrile, alcohol solvents such as ethanol and propylene glycol, and the like. These may be used alone or in combination of two or more. may
- pH adjusters examples include potassium dihydrogen phosphate, sodium dihydrogen phosphate, dipotassium hydrogen phosphate, disodium hydrogen phosphate, trishydroxymethylaminomethane, trishydroxymethylaminomethane hydrochloride, ethylenediaminetetraacetic acid, and the like. is mentioned. These may be used individually by 1 type, and may be used in combination of 2 or more type.
- composition of the present invention is prepared by sequentially mixing (a) a radical-generating catalyst, (b) a radical-generating source, (c) a thickening agent, (d) water, and, if desired, other components, and uniformly dissolving them. can.
- the composition of the present invention may be appropriately adjusted according to the purpose of application, but preferably has a viscosity of 0.005 to 600 Pa ⁇ s at 20°C.
- the viscosity at 20°C is 0.005 Pa ⁇ s or more, the object can be uniformly treated, and the composition tends to stay on the treated surface. Further, when the viscosity is 600 Pa ⁇ s or less, formulation design is easy and production efficiency is good.
- the difference between the viscosity at 20° C. before standing and the viscosity at 20° C. after standing is 50% or less. preferable.
- the viscosity difference in the test is 50% or less, the composition has excellent stability over time, and the quality of the product can be maintained.
- the difference in viscosity in the test is more preferably 20% or less, more preferably 10% or less.
- the composition of the present invention is preferably neutral or alkaline in nature.
- the radical generating source and the radical generating catalyst react rapidly to generate radicals, making it difficult to stably generate radicals for a long period of time.
- the aqueous radicals (active species) generated in the composition are maintained in a neutral or alkaline environment.
- bacteria, viruses, or the like to be reacted are present, the aqueous radicals present in the composition act to eliminate these radicals, but new radicals are generated from the composition. Thereby, radicals can be generated when necessary.
- the pH of the composition is more preferably 7-10, even more preferably 7-9.
- composition of the present invention can be used as, for example, a disinfectant, a deodorant, an antibacterial agent, an oral care agent, a human cleaning agent, a disinfectant, and the like.
- composition of the present invention may be applied to an object to be treated and spread directly by hand or by using a tool such as a spoon, spatula, or toothbrush.
- compositions of the present invention are not particularly limited, and can be applied to anything such as metal, plastic, glass, wood, paper, cloth, soil, stone, leaves, and the like. It can also be safely applied to humans and animals.
- the subject or site to be treated with the composition of the present invention is not particularly limited, but for example, medical instruments, human or animal skin, oral mucosa, hair, etc., furniture, home appliances, tableware, etc. Used in general homes and offices, etc. Examples include articles to be used, door knobs, window glass, fittings such as piping, and the like.
- the treatment amount of the composition of the present invention may be appropriately adjusted according to the object to be treated.
- it should be about 150 ⁇ g/cm 2 to 0.1 g/cm 2 . should be used.
- each component was mixed to prepare sample compositions of Examples 1-19.
- the viscosity of each sample composition was adjusted to 3 to 30 Pa ⁇ s.
- Example 7 2.0% by mass of propylene glycol was further added to the formulation of Table 2, and glucomannan was dissolved in propylene glycol and added to the composition.
- Sodium chlorite content (ppm) T x 0.22610 x f x 1000/collected amount of sample composition (g) (1)
- T is the amount (mL) of 0.01 mol/L sodium thiosulfate solution required for titration
- f is the factor of 0.01 mol/L sodium thiosulfate solution
- 0.01 mol/ 1 mL of L sodium thiosulfate solution corresponds to 0.22610 mg of sodium chlorite.
- the sample composition was stored at 40° C. for 2 weeks, and then the sodium chlorite content was quantified in the same manner (content after storage).
- Table 5 shows the content (initial content) of sodium chlorite in the sample composition before composition storage and the content after composition storage.
- Guard column "CAPCELL PAK C18 SG120 Cartridge Column S5" manufactured by Osaka Soda Co., Ltd. (inner diameter 4.0 mm, length 10 mm)
- Column temperature Constant temperature around 37°C
- Flow rate 1.0 mL/min
- Injection volume 50 ⁇ L
- Mobile phase 400 mL of water, 6.73 g of tetradecyltrimethylammonium bromide and 0.61 g of 2-amino-2-hydroxymethyl-1,3-propanediol were dissolved in 600 mL of methanol and adjusted to pH 7 with phosphoric acid.
- Example 4 (Confirmation of change in composition viscosity over time: Examples 11 to 15)
- the sample compositions of Examples 11 to 15 were stored at 25° C. and 40° C. for 3 months, respectively. Viscosity was measured over time during the storage period.
- an RB viscometer (“RB-85H” manufactured by Toki Sangyo Co., Ltd.) was used to measure the viscosity that stabilized at 20°C.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pest Control & Pesticides (AREA)
- Environmental Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Plant Pathology (AREA)
- Birds (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Agronomy & Crop Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Dentistry (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Toxicology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Description
近年、適用対象となる使用場所や使用目的、用途等に応じて適した剤型とするために製剤設計は多様化しており、このような多様化した要求に対応するため、ラジカルを発生させる組成物を新たな剤型で利用することが求められている。
(1)(a)ラジカル発生触媒、(b)ラジカル発生源、(c)増粘剤及び(d)水を含有する組成物。
(2)前記ラジカル発生触媒が、ルイス酸性度が0.4eV以上のルイス酸である、前記(1)に記載の組成物。
(3)前記ラジカル発生触媒が、下記化学式(I)で表されるアンモニウム塩を含む、前記(1)又は(2)に記載の組成物。
(4)前記化学式(I)で表されるアンモニウム塩が、下記化学式(II)で表されるアンモニウム塩である、前記(3)に記載の組成物。
(5)前記化学式(II)で表されるアンモニウム塩が、下記化学式(III)で表されるアンモニウム塩である、前記(4)に記載の組成物。
(6)前記ラジカル発生源が、亜ハロゲン酸、亜ハロゲン酸イオン及び亜ハロゲン酸塩からなる群から選択される少なくとも1種である、前記(1)に記載の組成物。
(7)前記組成物の性状が、中性又はアルカリ性である、前記(1)に記載の組成物。
尚、本明細書において、「質量」は「重量」と同義である。
本発明の組成物に含まれるラジカル発生触媒(以下、「本発明のラジカル発生触媒」ということがある。)は、ラジカル発生源からのラジカル発生を触媒するものであれば特に限定されず、既知の化合物を用いることができる。ラジカル発生触媒は、1種を単独で用いてもよく、2種以上を組み合わせて用いてもよい。
ルイス酸性度の上限値は、特に限定されないが、20eV以下であるのが好ましい。なお、ルイス酸性度は、例えば、Ohkubo, K.; Fukuzumi, S. Chem. Eur. J., 2000, 6, 4532、J. AM. CHEM. SOC. 2002, 124, 10270-10271、またはJ. Org. Chem. 2003, 68, 4720-4726に記載の方法により測定することができ、具体的には、下記の方法により測定することができる。
下記反応スキーム(A)中のコバルトテトラフェニルポルフィリン(CoTPP)、飽和O2およびルイス酸性度の測定対象物(例えば金属等のカチオンであり、下記反応スキーム(A)ではMn+で表される)を含むアセトニトリル(MeCN)を、室温において紫外可視吸収スペクトル変化の測定をする。得られた反応速度定数(kcat)からルイス酸性度の指標であるΔE値(eV)を算出することができる。kcatの値は大きいほど強いルイス酸性度を示す。また、有機化合物のルイス酸性度は、量子化学計算によって算出される最低空軌道(LUMO)のエネルギー準位からも、見積もることができる。正側に大きい値であるほど強いルイス酸性度を示す。
前記アルキル基は、炭素数1~40の直鎖または分枝アルキル基であるのが好ましい。
また、塩化ベンザルコニウムは、例えば、前記化学式(III)中、R11が炭素数8~18のアルキル基であり、X-が塩化物イオンである化合物として表すことができる。
ラジカル発生触媒の含有量は、組成物中、0.1~1000質量ppmであるのがより好ましく、0.1~500質量ppmがさらに好ましく、1~200質量ppmが特に好ましく、1~100質量ppmが最も好ましい。
なお、ミセル形成により殺菌効果等が得られなくなることを防止する観点からは、ラジカル発生触媒の濃度が、ミセル限界濃度以下であることが好ましい。
ラジカル発生源は、例えば、ハロゲンイオン、次亜ハロゲン酸イオン、亜ハロゲン酸イオン、ハロゲン酸イオン、過ハロゲン酸イオン等が挙げられ、これらからなる群から選択される少なくとも一つを含むのが好ましい。
ラジカル発生源は、例えば、オキソ酸またはその塩(例えば、ハロゲンオキソ酸またはその塩)を含んでいてもよい。前記オキソ酸としては、例えば、ホウ酸、炭酸、オルト炭酸、カルボン酸、ケイ酸、亜硝酸、硝酸、亜リン酸、リン酸、ヒ素、亜硫酸、硫酸、スルホン酸、スルフィン酸、クロム酸、ニクロム酸、及び過マンガン酸などが挙げられる。ハロゲンオキソ酸は、次亜塩素酸、亜塩素酸、塩素酸、及び過塩素酸などの塩素オキソ酸;次亜臭素酸、亜臭素酸、臭素酸、及び過臭素酸などの臭素オキソ酸;及び次亜ヨウ素酸、亜ヨウ素酸、ヨウ素酸、及び過ヨウ素酸などのヨウ素オキソ酸が挙げられる。また、これらの塩としては、ナトリウム、カリウム等のアルカリ金属塩が挙げられる。
具体的には、亜塩素酸ナトリウムが好ましい。
ラジカル発生源の含有量は、組成物中、1~1000質量ppmであるのがより好ましく、10~500質量ppmがさらに好ましく、50~250質量ppmが特に好ましい。
増粘剤としては、水溶性増粘剤が好適に使用できる。その中でも、ノニオン性増粘剤、両性増粘剤がよい。水溶性増粘剤としては、例えば、ヒドロキシプロピルセルロース、ヒドロキシプロピルメチルセルロース、メチルセルロースなどのセルロース系増粘剤、グルコマンナン、タマリンドガム、キサンタンガム、グァーガム、アラビアゴム、ローカストビーンガム、寒天等の多糖類(天然高分子);スメクタイトなどの無機高分子;ポリアクリル酸ナトリウム、架橋型ポリアクリル酸ナトリウム等のアクリル系高分子(合成高分子)などが挙げられる。これらは1種を単独で用いてもよく、2種以上を組み合わせて用いてもよい。
本発明の組成物は、ラジカル発生触媒、ラジカル発生源及び増粘剤を溶解又は分散させるための溶媒として、水を含む。
他の成分としては、例えば、有機溶剤、pH調整剤等が挙げられる。
本発明の組成物は、適用する目的に応じて適宜調整すればよいが、例えば、20℃における粘度が0.005~600Pa・sであるのが好ましい。20℃における粘度が0.005Pa・s以上であると、対象に対して均一に処理でき、組成物が処理面にとどまりやすい。また、粘度が600Pa・s以下であると、製剤設計がしやすく製造効率もよい。
前記試験における粘度の差は、20%以下であるのがより好ましく、10%以下がさらに好ましい。
組成物のpHは、7~10であるのがより好ましく、7~9がさらに好ましい。
本発明の組成物は、例えば、殺菌剤、消臭剤、抗菌剤、口腔ケア剤、人体用清浄剤、消毒剤等として用いることができる。
表2及び表3に示す処方に従い、各成分を混合し、実施例1~19の検体組成物を作製した。
なお、各検体組成物の粘度は、3~30Pa・sとなるようにした。
実施例7については、表2の処方にプロピレングリコール2.0質量%をさらに加え、グルコマンナンはプロピレングリコールに溶解させた状態で組成物に添加した。
(組成物の外観確認:実施例1~14)
実施例1~14の検体組成物について、調合直後に外観の変化を観察した。対照として、各増粘剤について表3に記載されたのと同濃度の水溶液を用い、色の比較を行った。
色の変化の見られないものを「A(良好)」、黄変や白濁があり、色の変化が見られたものを「B(不良)」とした。
結果を表4に示す。
(組成物中のラジカル発生源の含有量変化の確認:実施例1~19)
実施例1~19の検体組成物10gを正確に量り取り、それぞれに水70mLを加え、よく攪拌した。そこにヨウ化カリウム1gを加え、溶解させた。3%硫酸20mLを加えて、直ちに密栓し、冷暗所に15分静置し、0.01mol/Lチオ硫酸ナトリウム溶液で滴定し、以下の式(1)により、亜塩素酸ナトリウムの含有量を定量した(初期含有量)。
亜塩素酸ナトリウム含量(ppm)=T×0.22610×f×1000/検体組成物の採取量(g) ・・・(1)
式(1)中、Tは滴定までに要した0.01mol/Lチオ硫酸ナトリウム溶液の量(mL)であり、fは0.01mol/Lチオ硫酸ナトリウム溶液のファクターであり、0.01mol/Lチオ硫酸ナトリウム溶液1mLは亜塩素酸ナトリウム0.22610mgに相当する。
続いて、検体組成物を、40℃で2週間、静置保存した後、同様に、亜塩素酸ナトリウムの含有量を定量した(保存後含有量)。
(ラジカル発生源の含有量の経時変化の確認:実施例11~15)
実施例11~15の検体組成物を、25℃及び40℃でそれぞれ3ヶ月間、静置保存した。保存期間中、経時的に、下記条件にてHPLC分析を行い、亜塩素酸ナトリウムの含有量を定量した。
〔HPLC分析条件〕
分析機器:株式会社島津製作所製HPLC
検出器:株式会社島津製作所製紫外吸光光度計「SPD-20A」(波長270nm)
分析カラム:株式会社大阪ソーダ製「CAPCELL PAK C18 SG120」(内径4.6mm、長さ250mm)
ガードカラム:株式会社大阪ソーダ製「CAPCELL PAK C18 SG120カートリッジカラムS5」(内径4.0mm、長さ10mm)
カラム温度:37℃付近の一定温度
流速:1.0mL/min
注入量:50μL
移動相:メタノール600mLに水400mL、テトラデシルトリメチルアンモニウム臭化物6.73g及び2-アミノ-2-ヒドロキシメチル-1,3-プロパンジオール0.61gを溶解し、リン酸でpH7に調整した。
(組成物の粘度の経時変化の確認:実施例11~15)
実施例11~15の検体組成物を、25℃及び40℃でそれぞれ3ヶ月間、静置保存した。保存期間中、経時的に、粘度を測定した。
粘度の測定には、RB型粘度計(東機産業株式会社製「RB-85H」)を用いて、20℃で安定となる粘度を測定した。
これらより、セルロース系増粘剤が組成物粘度を安定させるのに優れていることがわかった。
Claims (7)
- (a)ラジカル発生触媒、(b)ラジカル発生源、(c)増粘剤及び(d)水を含有する組成物。
- 前記ラジカル発生触媒が、ルイス酸性度が0.4eV以上のルイス酸である、請求項1に記載の組成物。
- 前記ラジカル発生源が、亜ハロゲン酸、亜ハロゲン酸イオン及び亜ハロゲン酸塩からなる群から選択される少なくとも1種である、請求項1に記載の組成物。
- 前記組成物の性状が、中性又はアルカリ性である、請求項1に記載の組成物。
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202280057118.0A CN117835821A (zh) | 2021-08-25 | 2022-08-24 | 组合物 |
EP22861422.8A EP4393305A1 (en) | 2021-08-25 | 2022-08-24 | Composition |
JP2023543970A JPWO2023027134A1 (ja) | 2021-08-25 | 2022-08-24 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2021137556 | 2021-08-25 | ||
JP2021-137556 | 2021-08-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2023027134A1 true WO2023027134A1 (ja) | 2023-03-02 |
Family
ID=85322901
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2022/031963 WO2023027134A1 (ja) | 2021-08-25 | 2022-08-24 | 組成物 |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP4393305A1 (ja) |
JP (1) | JPWO2023027134A1 (ja) |
CN (1) | CN117835821A (ja) |
WO (1) | WO2023027134A1 (ja) |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5722102A (en) * | 1980-07-11 | 1982-02-05 | Daimaru Kogyo Kk | Composition for evolving chlorine dioxide and body packing it |
JPH0238301A (ja) * | 1988-06-08 | 1990-02-07 | Bristol Myers Co | 2酸化塩素含有化合物およびその製法 |
JP2012036072A (ja) * | 2010-08-09 | 2012-02-23 | Cleancare Inc | 用時二酸化塩素発生剤の製品形状ならびに成分組成 |
JP2017109978A (ja) | 2015-12-18 | 2017-06-22 | 株式会社 エースネット | 薬剤 |
CN107258839A (zh) * | 2017-07-12 | 2017-10-20 | 合肥华盖生物科技有限公司 | 一种复合消毒剂及其制备方法 |
JP2021137556A (ja) | 2020-03-09 | 2021-09-16 | アクティナ・コーポレーションAktina Corp. | リニアックのアイソセンタを決定するシステム、プロセス、及び装置 |
WO2022014675A1 (ja) * | 2020-07-16 | 2022-01-20 | 国立大学法人大阪大学 | 口腔用薬剤 |
JP2022082279A (ja) * | 2020-11-20 | 2022-06-01 | 株式会社冨士エンタープライズ | 感染症予防剤 |
CN114736743A (zh) * | 2022-04-25 | 2022-07-12 | 河南海康生物科技有限公司 | 一种清洁用品的生产工艺 |
-
2022
- 2022-08-24 WO PCT/JP2022/031963 patent/WO2023027134A1/ja active Application Filing
- 2022-08-24 JP JP2023543970A patent/JPWO2023027134A1/ja active Pending
- 2022-08-24 EP EP22861422.8A patent/EP4393305A1/en active Pending
- 2022-08-24 CN CN202280057118.0A patent/CN117835821A/zh active Pending
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5722102A (en) * | 1980-07-11 | 1982-02-05 | Daimaru Kogyo Kk | Composition for evolving chlorine dioxide and body packing it |
JPH0238301A (ja) * | 1988-06-08 | 1990-02-07 | Bristol Myers Co | 2酸化塩素含有化合物およびその製法 |
JP2012036072A (ja) * | 2010-08-09 | 2012-02-23 | Cleancare Inc | 用時二酸化塩素発生剤の製品形状ならびに成分組成 |
JP2017109978A (ja) | 2015-12-18 | 2017-06-22 | 株式会社 エースネット | 薬剤 |
CN107258839A (zh) * | 2017-07-12 | 2017-10-20 | 合肥华盖生物科技有限公司 | 一种复合消毒剂及其制备方法 |
JP2021137556A (ja) | 2020-03-09 | 2021-09-16 | アクティナ・コーポレーションAktina Corp. | リニアックのアイソセンタを決定するシステム、プロセス、及び装置 |
WO2022014675A1 (ja) * | 2020-07-16 | 2022-01-20 | 国立大学法人大阪大学 | 口腔用薬剤 |
JP2022082279A (ja) * | 2020-11-20 | 2022-06-01 | 株式会社冨士エンタープライズ | 感染症予防剤 |
CN114736743A (zh) * | 2022-04-25 | 2022-07-12 | 河南海康生物科技有限公司 | 一种清洁用品的生产工艺 |
Non-Patent Citations (3)
Title |
---|
J. AM. CHEM. SOC., vol. 124, 2002, pages 10270 - 10271 |
J. ORG. CHEM., vol. 68, 2003, pages 4720 - 4726 |
OHKUBO, K.FUKUZUMI, S., CHEM. EUR. J., vol. 6, 2000, pages 4532 |
Also Published As
Publication number | Publication date |
---|---|
JPWO2023027134A1 (ja) | 2023-03-02 |
EP4393305A1 (en) | 2024-07-03 |
CN117835821A (zh) | 2024-04-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6355926B2 (ja) | 安定化次亜ハロゲン酸溶液 | |
JP6236057B2 (ja) | 薬剤 | |
KR101925900B1 (ko) | 장기 보존성이 개선된 차아염소산수 및 그 제조 방법 | |
US20090074881A1 (en) | Antimicrobial cidality formulations with residual efficacy, uses thereof, and the preparation thereof | |
JP2012092153A (ja) | 第2抗菌剤を含むクエン酸二水素銀組成物 | |
JP2008506008A (ja) | 安定化高粘度過酸化水素含有組成物 | |
US20200171118A1 (en) | Radical generating catalyst, method for producing radical, method for producing oxidation reaction product, drug, and drug for use in agriculture and livestock industry | |
US20140328945A1 (en) | METHOD FOR STABILIZING AN ELECTROCHEMICALLY GENERATED SANITIZING SOLUTION HAVING A PREDETERMINED LEVEL OF FREE AVAILABLE CHLORINE AND pH | |
CN108617650A (zh) | 一种复合杀菌剂及其制备方法 | |
US11723361B2 (en) | Antimicrobial composition having efficacy against endospores | |
AU2016304773A1 (en) | Antimicrobial composition having efficacy against endospores | |
JP6706614B2 (ja) | 銀イオンと四級塩とを含む殺菌組成物 | |
JPWO2015093062A1 (ja) | 二酸化塩素吸着による亜塩素酸水製造法 | |
WO2023027134A1 (ja) | 組成物 | |
JP2009536649A5 (ja) | ||
WO2021066080A1 (ja) | 薬剤、薬剤の製造方法、および、水の浄化方法 | |
US20070264356A1 (en) | Process for the preparation of a ready-to-use disinfectant | |
CN116157109A (zh) | 口腔用药剂 | |
JP4680606B2 (ja) | 水系防カビ剤 | |
US20040180015A1 (en) | Long-acting disinfecting nitrous acid compositions and related processes | |
US6441045B1 (en) | Disinfectant composition | |
WO2023190598A1 (ja) | 組成物 | |
JP5441536B2 (ja) | 水系防カビ剤 | |
CN112690277A (zh) | 一种适用于医院学校室内空间的杀菌材料及其制备方法 | |
US20030004216A1 (en) | Disinfectant composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22861422 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2023543970 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 202280057118.0 Country of ref document: CN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2022861422 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2022861422 Country of ref document: EP Effective date: 20240325 |